UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

Journal of clinical oncology, 2019-08, Vol.37 (23), p.1997-2007

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1125-1132

2011

Link zum Volltext

Verfügbarkeit prüfen

Improved accuracy of discrimination between IgM Multiple Myeloma and Waldenström Macroglobulinaemia by testing for MYD88 L265P mutations

British journal of haematology, 2013-06, Vol.161 (6), p.902-904

2013

Link zum Volltext

Verfügbarkeit prüfen

Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas

Annals of hematology, 2020-09, Vol.99 (9), p.2125-2132

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics

PloS one, 2016-03, Vol.11 (3), p.e0147381

2016

Link zum Volltext

Verfügbarkeit prüfen

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies

International journal of molecular sciences, 2018-07, Vol.19 (7), p.2087

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats

Blood, 2011-11, Vol.118 (18), p.4977-4984

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentöse Tumortherapie

Haematologica (Roma), 2013-02, Vol.98 (2), p.264-268

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

International journal of hematology, 2022-02, Vol.115 (2), p.222-232

2022

Link zum Volltext

Verfügbarkeit prüfen

The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond

Cancers, 2021-09, Vol.13 (18), p.4701

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia

Zdravstveno varstvo, 2020-06, Vol.59 (2), p.83-91

2020

Link zum Volltext

Verfügbarkeit prüfen

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

The lancet oncology, 2018-03, Vol.19 (3), p.370-381

2018

Link zum Volltext

Verfügbarkeit prüfen

In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation

Annals of hematology, 2024-02, Vol.103 (2), p.553-563

2024

Link zum Volltext

Verfügbarkeit prüfen

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia

Wiener Klinische Wochenschrift, 2013, Vol.125 (1-2), p.50-53

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma

Blood, 2017-01, Vol.129 (3), p.383-385

2017

Link zum Volltext

Verfügbarkeit prüfen

P-488 Expert in the loop - AI assisted generation of real-world-evidence

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S308-S309

2023

Link zum Volltext

Verfügbarkeit prüfen

Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example

Experimental hematology, 2020-11, Vol.91, p.55-64

2020

Link zum Volltext

Verfügbarkeit prüfen

Ninreal - a Real World (RW) Comparison of Ixazomib Triplets and IMiD Duplets, in Relapsed and Refractory Multiple Myeloma (RRMM) from the Austrian Myeloma Registry (AMR)

Blood, 2022-11, Vol.140 (Supplement 1), p.13194-13195

2022

Link zum Volltext

Verfügbarkeit prüfen

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

The Lancet (British edition), 2017-12, Vol.390 (10114), p.2790-2802

2017

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow CD4+ and CD8+ Lymphocyte Infiltration Patterns Define Overall- and Progression Free Survival in Multiple Myeloma and May Predict IMiD Response: an Analysis from the Austrian Myeloma Registry

Blood, 2016-12, Vol.128 (22), p.5659-5659

2016

Link zum Volltext

Verfügbarkeit prüfen

In vitro antimyeloma activity of pixantrone (PIX)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19569-e19569

2014

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine plus Rituximab Versus R‐CHOP as First‐Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study

The oncologist (Dayton, Ohio), 2018-04, Vol.23 (4), p.454-460

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

ThemaCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Englisch
(141)
Deutsch
(9)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(65)
Humans
(47)
Oncology
(40)
Hematology
(34)
Female
(33)
Middle Aged
(30)
Male
(29)
Aged
(25)
Multiple Myeloma
(24)
Adult
(20)
Aged, 80 And Over
(15)
Medicine
(15)
Treatment Outcome
(15)
Medicine & Public Health
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Lymphoma
(12)
Multiple Myeloma - Drug Therapy
(11)
Patients
(10)
Retrospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

Improved accuracy of discrimination between IgM Multiple Myeloma and Waldenström Macroglobulinaemia by testing for MYD88 L265P mutations

Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentöse Tumortherapie

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study

The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond

Serologic Responses to COVID‐19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies

P943: OUTCOME ANALYSIS BY CYTOGENETIC RISK GROUP AFTER RANDOMIZATION TO KRD OR KTD FOLLOWED BY K MAINTENANCE OR CONTROL IN PATIENTS WITH NTE NDMM (AGMT MM‐02)

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma

P-488 Expert in the loop - AI assisted generation of real-world-evidence

Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example

Ninreal - a Real World (RW) Comparison of Ixazomib Triplets and IMiD Duplets, in Relapsed and Refractory Multiple Myeloma (RRMM) from the Austrian Myeloma Registry (AMR)

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Bone Marrow CD4+ and CD8+ Lymphocyte Infiltration Patterns Define Overall- and Progression Free Survival in Multiple Myeloma and May Predict IMiD Response: an Analysis from the Austrian Myeloma Registry

In vitro antimyeloma activity of pixantrone (PIX)

Bendamustine plus Rituximab Versus R‐CHOP as First‐Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study

Aktive Filter

Suchergebnisse filtern